A compound with validated biological activity, both in primary and secondary screens, against known targets.
Glossary
Lead
02.27.12
-
Breaking News | cGMP Manufacture | Fill/Finish | Industry News
LSNE, Selecta Biosciences Form Mfg. Pact
LSNE to provide drug substance manufacturing and fill/finish services
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
Selexis SA and OSE Immunotherapeutics Enter Pact
Sign agreement for the development of OSE's interleukin receptor 7 antagonist
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News | Preclinical Outsourcing | R&D
Nektar and Takeda in Research Collaboration
Will explore combination cancer therapies
-
Elemental Impurities: A Virtual Company Perspective
A look at risk assessments for elemental impurity determinations in oral tablet and parenteral drug products.Anthony DeStefano and Thomas Kester, Recordati Rare Diseases, Inc.
-
Chemistry | Collaborations & Alliances | Drug Discovery
Enamine, Actelion Expand Drug Discovery Collaboration
Enamine to provide library synthesis and medicinal chemistry services
